COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Isaac Newton Institute Seminar Series > Capital Adequacy, Pro-cyclicality and Systemic Risk
Capital Adequacy, Pro-cyclicality and Systemic RiskAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Mustapha Amrani. Systemic Risk: Mathematical Modelling and Interdisciplinary Approaches VaR-based capital adequacy as specified by Basel II accords is subject to procyclical effects, potentially aggravating systemic risk, when it is supposed to mitigate it, as observed during 2008 crisis. Supposed improvements in Basel III , not only dont resolve the problem, but introduce new sources of systemic risk. The method proposed here for computing the regulatory capital of financial institutions avoids the pitfalls of the Value-at-Risk. The computation is based on a generalized stress testing method, with the following principles: (i) market scenarios are defined by the regulator; (ii) institutions compute the impact of scenarios defined by the regulator and report them; (iii) the regulator not only counts the number of violations of the risk reporting but also their size; (iv) the regulatory capital is a multiple of the worst stress test, where the multiplier depends on the size and the frequency of the violations. By letting the institutions estimate their sensitivities to extreme market shifts, the regulator not only avoids a costly burden, but also keeps institutions responsible for their reporting. On the other hand, by keeping control on the list of stress tests involved in the computation of the capital, the regulator offers itself a very strong lever to prevent speculative bubbles, by making them costly in terms of capital requirements. This talk is part of the Isaac Newton Institute Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsScience@Darwin Life Science The Milner Therapeutics Institute: A new vehicle to facilitate academic/industry interactions in Cambridge Statistical Laboratory Open Afternoon Scientific Images Discussion Group Type the title of a new list hereOther talksElectoral intrigue, ethnic politics and the vibrancy of the Kenyan public sphere Mapping laboratory reports for molecular genetic testing to the National Cancer Registration and Analysis Service (NCRAS) Borel Local Lemma Simulating Neutron Star Mergers Leveraging the imaging power of the Beacon platform Panel comparisons: Challenor, Ginsbourger, Nobile, Teckentrup and Beck |